US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-21 17:58:21 Source：Worldly Window news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：With Djokovic awaiting the winner, Murray trails Hanfmann at rain
- Next：Amir Khan's £11.5m luxury wedding venue finally hosts its first marriage: Bride arrives on horse
Related articles
- Cruise worker 'murders newborn son on board ship': Shocked co
- Calls for implementing Gaza resolution grow
- U.S. experiencing 'full
- Beijing slams Washington on illegal claims of demarcation of seabed
- Jon Wysocki dead at 53: Staind drummer passes away
- Nations to enhance BRI ties
- China to do utmost to restore peace in Gaza: FM spokesperson
- Xi calls for closer ties with Vietnam
- I was 'brokefished' by my friend for £400
- China strongly condemns provocative visit of UK politicians to the island of Taiwan
- Sweden beats France, Britain relegated after losing to Norway at hockey worlds
- Cyberattack accusations 'irresponsible'
- UN Security Council adopts first cease
- China intensifies efforts for cease
- Biden says Brown v. Board of Education ruling was about more than education
- Ambassador encourages education exchanges between China and UK
- Beijing slams Washington on illegal claims of demarcation of seabed
- Washington urged to respect rule of law in Hong Kong
- Yvette Fielding says her Most Haunted co
- Israel pulls troops out of southern Gaza
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Worldly Window news portal sitemap